Use of arginine as an immunostimulator
US5576351A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Nov 16, 1994 |
| Grant date | Nov 19, 1996 |
| Priority date | — |
| Expiry date | Nov 16, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA23L33/40
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the treatment of an impaired human immune response or to reduction of the severity of degradation of the human immune response by the administration of arginine or ornithine, or a functional analog of arginine or ornithine, or mixtures thereof, to humans suffering from an impaired immune response or at risk of suffering an impaired immune response. Such treatment is provided by enterally administering compositions supplemented with arginine or ornithine, or functional analogs of arginine or ornithine, or parenterally administering amino acid solutions supplemented with arginine or ornithine, or functional analogs of arginine or ornithine, to the patient.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.